The European electronic database on medical devices (EUDAMED) is moving towards a mandatory regulatory infrastructure. With the Commission Decision (EU) 2025/2371 and the transitional provisions in Regulation (EU) 2024/1860, economic operators face a fixed deadline after which new devices must be registered in EUDAMED before placement on the EU market.
In November 2025, the EU published Commission Decision (EU) 2025/2371, officially confirming that four core modules of EUDAMED are now functional and meet the required technical specifications. Under the transitional timelines established by Regulation (EU) 2024/1860, this triggered a six‑month countdown to mandatory use of the following modules:
Following the formal declaration of full functionality of the relevant EUDAMED modules, registration via these modules becomes compulsory for all economic operators and products falling under the MDR and IVDR from May 28, 2026. This means that any new device you intend to place on the EU market after this date must be registered in EUDAMED using the appropriate modules before commercialization. Failing to do so will hold up compliance and, in many cases, can prevent lawful entry into the European market.
A European Authorize Representative (EU Rep) acts as the legal representative for non‑EU manufacturers entering the European market. Key responsibilities linked to EUDAMED include:
1. Facilitating Actor Registration & Single Registration Numbers (SRN)
The legal manufacturer's entity must be properly registered in the EUDAMED actor module and receive an SRN after successful registation. The European Authorized Representative role must be accurately reflected in EUDAMED as well. This includes ensuring that the manufacturer provides the necessary mandate summary document during actor registration.
2. Supporting UDI/Data Submission
Under the MDR and IVDR, each device must have a Unique Device Identifier (UDI) and be categorized according to the European Medical Device Nomenclature (EMDN). While the manufacturer holds primary responsibility for device data accuracy, an EU Rep coordinates and reviews the submission, especially around classification, nomenclature (EMDN), and UDI allocators. This coordination ensures that data is complete, technically valid, and structured per EU expectations before final submission.
3. Liaison with Notified Bodies
While this module is primarily for notified body data (such as certificates issued), it links directly to your device records, especially for higher risk products requiring conformity assessment. For products requiring a conformity assessment by a Notified Body, the EU Rep confirms that certificate data is reflected correctly in the Notified Bodies & Certificates module.
4. Post‑Submission Compliance Monitoring / Market Surveillance
After product registration, the EU Rep is still responsible for tracking statuses, responding to competent authority queries, monitoring safety and supporting compliance as regulatory landscapes evolve. Once products are registered, the data continuity across modules supports ongoing compliance.
Note: Two other modules (1) Clinical Investigations & Performance Studies and (2) Vigilance & Post‑Market Surveillance, are not yet mandatory but will become so later in the EUDAMED rollout.
First EUDAMED product registrations present several recurring friction points. Here’s what we see most and how to mitigate it:
- Actor & UDI Preparation Underestimated
Many manufacturers delay actor registration until device submission time, only to discover missing documentation or SRN delays.
Solution: Start actor registration well before planned device submission. Ensure that your mandate summary document and security declarations are submitted early, so your SRN is issued with time to spare.
- Complexity of UDI and EMDN Coding
UDI submissions require accurate data structuring according to complex schemas, and appropriate EMDN classification. Every submission must pass rigorous validation rules before acceptance. Manufacturers often underestimate the complex data architecture, lack dedicated personnel, or are not equipped with additional IT systems.
Solution: Many organisations find that outsourcing preparation and submission can significantly reduce internal burden, minimise errors, and accelerate timelines.
- Interfacing with Notified Bodies
Certificate data linkage can hold up device status updates. Notified Bodies may take more time than anticipated.
Solution: Early engagement and clear coordination with your Notified Body ensure their submissions are aligned to your device's UDI records and regulatory timelines.
If you’re planning your first EUDAMED submission and want specific support checklists, templates, or personalized guidance, Qserve can act as your EU Authorized Representative and support EUDAMED onboarding, UDI submissions, update and expansions.